Phoenix Life Sciences International Limited
PLSI · OTC
2/28/2019 | 2/28/2018 | 2/28/2017 | 2/29/2016 | |
|---|---|---|---|---|
| Market Cap | $367 | $747 | $59 | $137 |
| - Cash | $202 | $1 | $1 | $8 |
| + Debt | $36 | $416 | $333 | $193 |
| Enterprise Value | $201 | $1,162 | $390 | $322 |
| Revenue | $0 | $0 | $0 | $18 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | $12 |
| % Margin | – | – | – | 67.8% |
| EBITDA | -$3,061 | -$0 | -$36 | -$355 |
| % Margin | – | – | – | -1,930.7% |
| Net Income | -$3,117 | -$77 | -$255 | -$788 |
| % Margin | – | – | – | -4,279.3% |
| EPS Diluted | -89.11 | -2.46 | -8.63 | -28.81 |
| % Growth | -3,522.4% | 71.5% | 70% | – |
| Operating Cash Flow | -$860 | -$0 | -$20 | -$228 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$860 | -$0 | -$20 | -$228 |